m. GHASEMİ Et Al. , "The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.," Journal Of The Renin-Angiotensin-Aldosterone System , 2019
GHASEMİ, m. Et Al. 2019. The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.. Journal Of The Renin-Angiotensin-Aldosterone System .
GHASEMİ, m., OKAY, M., TÜRK, S., HAZNEDAROĞLU, İ. C., AKSU, S., SAYINALP, N., ... MALKAN, Ü. Y.(2019). The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.. Journal Of The Renin-Angiotensin-Aldosterone System .
GHASEMİ, mehdi Et Al. "The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.," Journal Of The Renin-Angiotensin-Aldosterone System , 2019
GHASEMİ, mehdi Et Al. "The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.." Journal Of The Renin-Angiotensin-Aldosterone System , 2019
GHASEMİ, m. Et Al. (2019) . "The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.." Journal Of The Renin-Angiotensin-Aldosterone System .
@article{article, author={mehdi GHASEMİ Et Al. }, title={The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.}, journal={Journal Of The Renin-Angiotensin-Aldosterone System}, year=2019}